Daniel Kim, DO
Pulmonary Disease · Manchester, NHNPI 1912986530
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $2,500 of the $3,397 with a category attached, or 73.6%. Noah Medical Corporation accounts for 73.6% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2023 at $2,582 and has fallen 89.0% since, to $283 in 2025.
Across 15 payments — averaging $226.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Noah Medical Corporation$3K
- Teleflex LLC$191
- Nevro Corp.$127
- Boehringer Ingelheim$125
- Actelion Pharmaceuticals US, Inc.$102
- Regeneron Healthcare Solutions, Inc.$97
- plus $256 from 6 others
What the payments were for
- Consulting fees$2,50074%
- Food & beverage$89726%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Noah Medical Corporation | 1 | $2,500 |
| Teleflex LLC | 3 | $191 |
| Nevro Corp. | 1 | $127 |
| Boehringer Ingelheim | 1 | $125 |
| Actelion Pharmaceuticals US, Inc. | 1 | $102 |
| Regeneron Healthcare Solutions, Inc. | 1 | $97 |
| Verona Pharma, Inc. | 1 | $92 |
| Baxter Healthcare | 1 | $82 |
| GSK | 2 | $36 |
| Mylan Specialty L.p. | 1 | $17 |
| Sanofi Pasteur Inc. | 1 | $15 |
| Sunovion Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Barrigel$128
- Senza Spinal Cord Stimulation System$127
- UPTRAVI$102
- OPSUMIT$102
How this compares
$3,397 in reported general payments places this provider in the 80th percentile of 78 pulmonary disease providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Manchester
- David CondonManchester$1K
- Shweta GuptaManchester$551
- Haitham Al AshryManchester$278
- Muhammad MirzaManchester$225
- Anna AbbasiManchester$177
- Richard ReadManchester$100
- Beth FisherManchester$78
- Matthew CurleyManchester$72
- Donald MahlerLebanon$411K
- Bianca MonteiroDover$43K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.